Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Antinuclear antibody, Blood thyroid stimulating hormone, C-reactive protein increased, Free thyroxine index, Hypoaesthesia
Clinical narrative: numbness and tingling in her legs and feet; Tingling in limbs, hands, feet and tongue for 3 1/2 months.; Tingling in limbs, hands, feet and tongue for 3 1/2 months.; Tingling in limbs, hands, feet and tongue for 3 1/2 months.; This is a spontaneous report from a contactable consumer (patient). A 73-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL9266), via intramuscular route of administration, administered in Arm Right on 22Feb2021 at 10:30 as dose 2, single for covid-19 immunisation (vaccinated at 72years old and not pregnant at time of vaccination). Medical history included allergy with penicillin, ongoing anxiety from 22Mar2021, ongoing paraesthesia from 22Mar2021, ongoing chest pain from 22Mar2021 -all diagnosed when patient came due to tingling from vaccine. Concomitant medications in two weeks included nadolol (NADOLOL, dose: 80 mg) taken for arrhythmia from 29Feb2012 to ongoing; ezetimibe, simvastatin (VYTORIN); omega-3-acid ethyl ester (LOVAZA); ezetimibe, simvastatin (EZETIMIBE and SIMVASTATIN, dose: 10-4mg) taken for hypercholesterolaemia from 18Nov2010 to ongoing; eicosapentaenoic acid ethyl ester (VASCEPA, dose: 1 g) taken for hypercholesterolaemia from 03Dec2020 to ongoing; sertraline hydrochloride (ZOLOFT, dose: 50 mg) taken for anxiety from 19Apr2021 to ongoing; escitalopram oxalate (LEXAPRO, dose: 10 mg) taken for anxiety from 22Mar2021 to 10Apr2021, discontinued Lexapro due to feeling sick to her stomach. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, lot number: EL9265, patient was 72-year-old at the time of vaccination), via intramuscular route of administration, administered in Arm Right on 01Feb2021 at 10:30AM as dose 1, single for covid-19 immunisation. No other vaccine in four weeks received. No covid prior vaccination. No covid tested post vaccination. No prior vaccination received. Patient did have an MRI Brain u1 and u10 contrast 3 days prior to first shot due to Migraine w/ aura. MRI was normal except for some white spots and mucosal thickening. Patient came in for a visit on 22Mar2021 due to numbness and tingling in her legs and feet. Doctor diagnosed her with other chest pain (R0789) Parasthesias (RZO.Z) Anxiety (F419). Patient Rx new med Lexapro discontinued after 18 days and then began Zoloft half of 50 mg. She came in for a follow up in 03May2021. Discussed anxiety, Parasthesias and abnormal Thyroid labs. She did labs. She was referred to Neurology and has appointment in Jun2021. On 23Feb2021 at 08:00, the patient experienced tingling in limbs, hands, feet and tongue for 3 1/2 months. On 22Mar2021, numbness and tingling in her legs and feet. AE(s) resulted to visit doctor or other healthcare professional office/clinic visit. 03May2021, the patient underwent lab tests and procedures which included ANA screen direct resulted as negative, TSH resulted as 2.060 mlu/dL having normal value 0.300- 4.000, c-reactive protein resulted as 21 mg/l having normal value 0-10, FT4 resulted as 0.970 ug/dl having normal value 0.700-1.530, ESR resulted as 8 mmhg having normal value 0-20, FT3 resulted as 4.000 pg/ml having normal value 2.300- 4.200, vitamin B12 resulted as 680 pg/ml having normal value 211-946. These labs were done when patient came due to the tingling. Patient received treatment for events (tingling in limbs, hands, feet and tongue for 3 1/2 months) with . the outcome s of events (Tingling in limbs, hands, feet and tongue for 3 1/2 months.) was not recovered, and the event (numbness and tingling in her legs and feet) was unknown.  Information on Lot/Batch number was available. Additional information has been requested.